Hans-Peter Gerber
Direttore Tecnico/Scientifico/R&S presso SUTRO BIOPHARMA, INC.
Patrimonio netto: - $ in data 30/04/2024
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Jane Chung | F | 53 | 3 anni | |
| William Newell | M | 66 | 15 anni | |
| Connie Matsui | F | 70 | 5 anni | |
| Michael Dybbs | M | 49 | 6 anni | |
| Robert DuBridge | M | - |
Maverick Therapeutics, Inc.
 Maverick Therapeutics, Inc. BiotechnologyHealth Technology Maverick Therapeutics, Inc. operates as a preclinical stage biotech company. It develops a novel class of T cell- redirecting antibody therapeutics that have the potential to substantially broaden the range of targets and clinical applications to be used for this ultra-potent mechanism. The company was founded by Robert Dubridge and Patrick A. Baeuerle in 2016 and is headquartered in Brisbane, CA. | 8 anni |
| Nicki Vasquez | M | 61 | 9 anni | |
| Jon Wigginton | M | 62 | 4 anni | |
| Heidi Hunter | F | 66 | 3 anni | |
| James Panek | M | 71 | 4 anni | |
| Henry Heinsohn | M | - | - | |
| Erich Schlick | M | 72 |
NBE-Therapeutics AG
 NBE-Therapeutics AG BiotechnologyHealth Technology NBE-Therapeutics AG operates as biotechnology company. It develops next-generation ADCs improving treatment options for cancer patients. The company was founded by Ulf Grawunder in 2012 and is based in Basel, Swizerland. | 4 anni |
| Edward Albini | M | 66 | 11 anni | |
| Daniel Petree | M | 68 | - | |
| Joseph Lobacki | M | 65 | 7 anni | |
| John Freund | M | 70 | 10 anni | |
| Linda Fitzpatrick | F | 67 | 16 anni | |
| James Scibetta | M | 59 |
Maverick Therapeutics, Inc.
Maverick Therapeutics, Inc. BiotechnologyHealth Technology Maverick Therapeutics, Inc. operates as a preclinical stage biotech company. It develops a novel class of T cell- redirecting antibody therapeutics that have the potential to substantially broaden the range of targets and clinical applications to be used for this ultra-potent mechanism. The company was founded by Robert Dubridge and Patrick A. Baeuerle in 2016 and is headquartered in Brisbane, CA. | 7 anni |
| Ulf Grawunder | M | 59 |
T-CURX GmbH
| 2 anni |
| Bertrand Damour | M | - |
NBE-Therapeutics AG
NBE-Therapeutics AG BiotechnologyHealth Technology NBE-Therapeutics AG operates as biotechnology company. It develops next-generation ADCs improving treatment options for cancer patients. The company was founded by Ulf Grawunder in 2012 and is based in Basel, Swizerland. | 4 anni |
| Anne Borgman | M | 56 | 1 anni | |
| Craig Berman | M | - | 4 anni | |
| Regina Cheng | F | - | 4 anni | |
| Diana Landa | F | - | 4 anni | |
| Carlos Lugo | M | - | - | |
| David Pauling | M | - | - | |
| Werner Rubas | M | - | 3 anni | |
| Steve Michel | M | - | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Nicole Onetto | M | 71 |
NBE-Therapeutics AG
NBE-Therapeutics AG BiotechnologyHealth Technology NBE-Therapeutics AG operates as biotechnology company. It develops next-generation ADCs improving treatment options for cancer patients. The company was founded by Ulf Grawunder in 2012 and is based in Basel, Swizerland. | 4 anni |
| Patrick Baeuerle | M | 66 |
Maverick Therapeutics, Inc.
Maverick Therapeutics, Inc. BiotechnologyHealth Technology Maverick Therapeutics, Inc. operates as a preclinical stage biotech company. It develops a novel class of T cell- redirecting antibody therapeutics that have the potential to substantially broaden the range of targets and clinical applications to be used for this ultra-potent mechanism. The company was founded by Robert Dubridge and Patrick A. Baeuerle in 2016 and is headquartered in Brisbane, CA. | - |
| Theo H. Walthie | M | 76 |
NBE-Therapeutics AG
NBE-Therapeutics AG BiotechnologyHealth Technology NBE-Therapeutics AG operates as biotechnology company. It develops next-generation ADCs improving treatment options for cancer patients. The company was founded by Ulf Grawunder in 2012 and is based in Basel, Swizerland. | - |
| Brunilda Shtylla | F | 49 | 4 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 26 | 83.87% |
| Svizzera | 4 | 12.90% |
| Germania | 1 | 3.23% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Hans-Peter Gerber
- Contatti personali